Intra-Cellular Therapies Inc (ITCI)
85.51
-0.13
(-0.15%)
USD |
NASDAQ |
Nov 21, 16:00
85.51
0.00 (0.00%)
After-Hours: 20:00
Intra-Cellular Therapies Price to Book Value: 7.919 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 7.931 |
| November 19, 2024 | 7.719 |
| November 18, 2024 | 7.637 |
| November 15, 2024 | 7.725 |
| November 14, 2024 | 8.115 |
| November 13, 2024 | 8.170 |
| November 12, 2024 | 8.195 |
| November 11, 2024 | 8.480 |
| November 08, 2024 | 8.454 |
| November 07, 2024 | 8.382 |
| November 06, 2024 | 8.283 |
| November 05, 2024 | 8.264 |
| November 04, 2024 | 7.980 |
| November 01, 2024 | 8.014 |
| October 31, 2024 | 7.848 |
| October 30, 2024 | 7.915 |
| October 29, 2024 | 7.108 |
| October 28, 2024 | 7.114 |
| October 25, 2024 | 7.019 |
| October 24, 2024 | 7.004 |
| October 23, 2024 | 6.946 |
| October 22, 2024 | 7.138 |
| October 21, 2024 | 7.121 |
| October 18, 2024 | 7.254 |
| October 17, 2024 | 7.285 |
| Date | Value |
|---|---|
| October 16, 2024 | 7.045 |
| October 15, 2024 | 6.917 |
| October 14, 2024 | 6.837 |
| October 11, 2024 | 7.015 |
| October 10, 2024 | 6.816 |
| October 09, 2024 | 6.781 |
| October 08, 2024 | 6.703 |
| October 07, 2024 | 6.591 |
| October 04, 2024 | 6.749 |
| October 03, 2024 | 6.690 |
| October 02, 2024 | 6.724 |
| October 01, 2024 | 6.727 |
| September 30, 2024 | 6.775 |
| September 27, 2024 | 6.767 |
| September 26, 2024 | 6.758 |
| September 25, 2024 | 6.866 |
| September 24, 2024 | 6.972 |
| September 23, 2024 | 6.998 |
| September 20, 2024 | 7.165 |
| September 19, 2024 | 7.106 |
| September 18, 2024 | 6.896 |
| September 17, 2024 | 6.934 |
| September 16, 2024 | 6.948 |
| September 13, 2024 | 6.959 |
| September 12, 2024 | 6.944 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.207
Minimum
Apr 02 2020
13.91
Maximum
Mar 29 2022
7.078
Average
6.944
Median
Price to Book Value Benchmarks
| Ionis Pharmaceuticals Inc | 8.091 |
| AbbVie Inc | 50.30 |
| NovaBay Pharmaceuticals Inc | 3.291 |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.263 |
Price to Book Value Related Metrics
| PS Ratio | 14.05 |
| Price | 85.51 |
| Earnings Yield | -1.02% |
| Market Cap | 9.066B |